
Denatonium benzoate
CAS No. 3734-33-6
Denatonium benzoate( Lidocaine benzyl benzoate | NSC 157658 | WIN 16,568 )
Catalog No. M14290 CAS No. 3734-33-6
Denatonium is a quaternary ammonium cation. It is a compound of a salt with an inert anion like benzoate or saccharide.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
50MG | 30 | In Stock |
![]() ![]() |
100MG | 42 | In Stock |
![]() ![]() |
200MG | 61 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameDenatonium benzoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionDenatonium is a quaternary ammonium cation. It is a compound of a salt with an inert anion like benzoate or saccharide.
-
DescriptionDenatonium is a quaternary ammonium cation. It is a compound of a salt with an inert anion like benzoate or saccharide. The structure of denatonium is related to the local anesthetic lidocaine, differing only by the addition of a benzyl group to the amino nitrogen.
-
In Vitro——
-
In Vivo——
-
SynonymsLidocaine benzyl benzoate | NSC 157658 | WIN 16,568
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3734-33-6
-
Formula Weight446.58
-
Molecular FormulaC28H34N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILES[O-]C(=O)C1=CC=CC=C1.CC[N+](CC)(CC(=O)NC1=C(C)C=CC=C1C)CC1=CC=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Meyerhof W, et al. Chem Senses. 2010 Feb;35(2):157-70.
molnova catalog



related products
-
BNP-45 (rat) (TFA) (...
BNP-45 (rat) TFA is a circulating form of rat brain natriuretic peptide isolated from rat heart with potent hypotensive and natriuretic potency.
-
Deoxynivalenol
Deoxynivalenol (Vomitoxin) is a mycotoxin produced by Fusarium spp. of the single trichothecene family and is commonly found in contaminated food and feed.
-
Hancinone C
Hancinone C shows inhibitory activity against the platelet aggregation caused by PAF.